Sevelamer Hydrochloride in Peritoneal Dialysis Patients
Condition(s):Endstage Renal DiseaseLast Updated:June 18, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Endstage Renal DiseaseLast Updated:June 18, 2020Completed
Condition(s):Kidney Diseases; Chronic Renal Insufficiency; End-Stage Renal DiseaseLast Updated:March 19, 2014Completed
Condition(s):Chronic Kidney DiseaseLast Updated:March 18, 2015Completed
Condition(s):Dialysis; Cardiovascular Disease; Atherosclerosis; Inflammation; HyperphosphatemiaLast Updated:July 31, 2017Terminated
Condition(s):End Stage Renal Disease; Hemodialysis; Intimal Media ThicknessLast Updated:January 14, 2010Completed
Condition(s):Chronic Kidney Disease, Stage 5Last Updated:June 11, 2021Completed
Condition(s):Chronic Kidney Disease; HyperphosphatemiaLast Updated:March 24, 2015Terminated
Condition(s):Hyperphosphatemia; Chronic Kidney DiseaseLast Updated:July 25, 2016Completed
Condition(s):HyperphosphatemiaLast Updated:March 25, 2022Completed
Condition(s):Chronic Renal FailureLast Updated:April 28, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.